Amarin Corp Plcuk (AMRN) Net Margin (2013 - 2026)

Amarin Corp Plcuk (AMRN) reported Net Margin of 23.29% for Q1 2026, up 1407.0% year-over-year from 1.55% in Q1 2025, and down 836.6% quarter-over-quarter from 2.49% in Q4 2025.

Amarin Corp Plcuk (AMRN) Net Margin (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 14 years of Net Margin data on file, last reported at 23.29% in Q1 2026.

  • Net Margin for Q1 2026 came in at 23.29%, up 1407.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 15.51% (up 2556.0% YoY), and the FY2025 annual result was 18.16%, up 1779.0% from the prior year.
  • Net Margin eased to 23.29% in Q1 2026 per AMRN's latest filing, from 2.49% in the prior quarter.
  • Over five years, Net Margin peaked at 2.26% in Q2 2024 and troughed at 78.03% in Q4 2024.
  • A 5-year average of 25.95% and a median of 19.44% in 2025 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2022 and 2025: Net Margin tumbled 7913 bps in 2022, then jumped 7554 bps in 2025.
  • A 5-year view of Net Margin shows it stood at 0.95% in 2022, then sank by 916 bps to 7.74% in 2023, then tumbled by 908 bps to 78.03% in 2024, then surged by 97 bps to 2.49% in 2025, then plunged by 837 bps to 23.29% in 2026.
  • Business Quant data shows AMRN's Net Margin at 23.29% in Q1 2026, 2.49% in Q4 2025, and 15.58% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 22.77%
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 37.36%
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 21.76%
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 4.65%
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -25.84%
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 21.11%
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 29.04%
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -0.56%
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 23.32%
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -23.29%

Historic Data

Download Data
DateValue
Mar 31, 2026 -23.29%
Dec 31, 2025 -2.49%
Sep 30, 2025 -15.58%
Jun 30, 2025 -19.44%
Mar 31, 2025 -37.36%
Dec 31, 2024 -78.03%
Sep 30, 2024 -59.42%
Jun 30, 2024 2.26%
Mar 31, 2024 -17.61%
Dec 31, 2023 -7.74%
Sep 30, 2023 -29.23%
Jun 30, 2023 -21.90%
Mar 31, 2023 -19.15%
Dec 31, 2022 0.95%
Sep 30, 2022 -5.72%
Jun 30, 2022 -74.07%
Mar 31, 2022 -33.35%
Dec 31, 2021 10.17%
Sep 30, 2021 -9.26%
Jun 30, 2021 5.05%